We are live on ! Find out more
CC

Callan Capital Portfolio holdings

AUM $1.35B Turnover 17.35%
1-Year Est. Return 8.35%
This Fund
S&P 500
This Quarter Est. Return
+2.13%
1 Year Est. Return
+8.35%
3 Year Est. Return
+20.11%
5 Year Est. Return
+98.58%
10 Year Est. Return
+95.87%
AUM
$1.22B
AUM Growth
+$77.6M
Cap. Flow
+$59.9M
Cap. Flow %
4.93%
Top 10 Hldgs %
46.33%
Holding
332
New
35
Increased
189
Reduced
69
Closed
18
Avg Time Held Equity + Options
2.2 years
Top 10 Avg Time Held Equity + Options
3.2 years
Top 20 Avg Time Held Equity + Options
4 years
Avg Time Held Equity only
2.2 years
Top 10 Avg Time Held Equity only
3.2 years
Top 20 Avg Time Held Equity only
4 years

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$18.4M
2
NMRA icon
Neumora Therapeutics
NMRA
+$4.72M
3
IJH icon
iShares Core S&P Mid-Cap ETF
IJH
+$3.83M
4
AVUV icon
Avantis US Small Cap Value ETF
AVUV
+$3.67M
5
IVW icon
iShares S&P 500 Growth ETF
IVW
+$3.3M

Top Sells

Rank Stock Value
1
VTEB icon
Vanguard Tax-Exempt Bond Index Fund
VTEB
+$1.96M
2
GSIE icon
Goldman Sachs ActiveBeta International Equity ETF
GSIE
+$906K
3
INTF icon
iShares International Equity Factor ETF
INTF
+$852K
4
AVUS icon
Avantis US Equity ETF
AVUS
+$644K
5
DISV icon
Dimensional International Small Cap Value ETF
DISV
+$589K

Sector Composition

Rank Sector Weight
1 Miscellaneous 82.41%
2 Technology 7.75%
3 Healthcare 2.78%
4 Financials 1.79%
5 Communication Services 1.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
VAW icon
101
Vanguard Materials ETF
VAW
$3.23B
$1.19M 0.1%
6,194
-439
-7% -$87.2K
2018 Q1
25 quarters
IWM icon
102
iShares Russell 2000 ETF
IWM
$76.2B
$1.18M 0.1%
5,809
+1,190
+26% +$240K
2023 Q2
4 quarters
XOM icon
103
ExxonMobil
XOM
$736B
$1.17M 0.1%
10,135
+3,058
+43% +$356K
2022 Q4
6 quarters
BAC icon
104
Bank of America
BAC
$358B
$1.07M 0.09%
26,871
+2,019
+8% +$77.4K
2022 Q4
6 quarters
IX icon
105
ORIX
IX
$39.7B
$1.05M 0.09%
47,275
+9,060
+24% +$193K
2024 Q1
1 quarter
TSM icon
106
TSMC
TSM
$2.14T
$1.04M 0.09%
5,997
+480
+9% +$72.8K
2023 Q3
3 quarters
ABBV icon
107
AbbVie
ABBV
$504B
$1.04M 0.09%
6,063
+66
+1% +$10.9K
2022 Q3
7 quarters
ARE icon
108
Alexandria Real Estate Equities
ARE
$7.16B
$1.03M 0.09%
8,843
-531
-6% -$63.3K
2022 Q4
6 quarters
BX icon
109
Blackstone
BX
$85.1B
$986K 0.08%
7,968
+1,386
+21% +$171K
2022 Q4
6 quarters
NVS icon
110
Novartis
NVS
$286B
$957K 0.08%
8,988
+1,762
+24% +$177K
2023 Q4
2 quarters
HMC icon
111
Honda
HMC
$44.5B
$934K 0.08%
28,965
+7,166
+33% +$242K
2023 Q4
2 quarters
JNJ icon
112
Johnson & Johnson
JNJ
$616B
$934K 0.08%
6,388
+740
+13% +$110K
2021 Q4
10 quarters
VSS icon
113
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.3B
$916K 0.08%
7,800
-38
-0.5% -$4.46K
2021 Q4
10 quarters
PEP icon
114
PepsiCo
PEP
$179B
$908K 0.07%
5,507
+255
+5% +$44K
2020 Q1
17 quarters
EPD icon
115
Enterprise Products Partners
EPD
$79.5B
$900K 0.07%
31,057
+7,671
+33% +$220K
2023 Q3
3 quarters
VEA icon
116
Vanguard FTSE Developed Markets ETF
VEA
$228B
$886K 0.07%
17,924
-459
-2% -$22.8K
2022 Q1
9 quarters
SAP icon
117
SAP
SAP
$259B
$882K 0.07%
4,371
+494
+13% +$93.3K
2023 Q4
2 quarters
GE icon
118
GE Aerospace
GE
$326B
$878K 0.07%
5,525
+2,900
+110% +$463K
2024 Q1
1 quarter
NEE icon
119
NextEra Energy
NEE
$166B
$852K 0.07%
12,036
+2,655
+28% +$188K
2021 Q4
10 quarters
TM icon
120
Toyota
TM
$229B
$851K 0.07%
4,153
+321
+8% +$71K
2023 Q4
2 quarters
DHR icon
121
Danaher
DHR
$161B
$839K 0.07%
3,358
+2,347
+232% +$593K
2024 Q1
1 quarter
AMGN icon
122
Amgen
AMGN
$234B
$828K 0.07%
2,649
+27
+1% +$7.93K
2020 Q1
17 quarters
HYG icon
123
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.8B
$826K 0.07%
10,705
+3,100
+41% +$238K
2023 Q4
2 quarters
AZN icon
124
AstraZeneca
AZN
$257B
$808K 0.07%
5,179
+2,638
+104% +$397K
2022 Q4
6 quarters
MA icon
125
Mastercard
MA
$541B
$800K 0.07%
1,814
-55
-3% -$25.1K
2020 Q1
17 quarters
3 4
5
6 7

Similar funds

PRO
Pensioenfonds Rail & OV Utrecht, Netherlands $1.44B AUM 2.6% 1-Year Est. Return
MBA
Maple-Brown Abbott Barangaroo, Australia $1.47B AUM 27.26% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return
AP
Adero Partners Pleasanton, California $1.53B AUM 5.52% 1-Year Est. Return
MW
Marcum Wealth Cleveland, Ohio $1.16B AUM 6.7% 1-Year Est. Return
SBIA
Sheaff Brock Investment Advisors Indianapolis, Indiana $1.09B AUM 14.4% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return
TW
Transform Wealth Greenwood Village, Colorado $1.65B AUM 19.1% 1-Year Est. Return

Callan Capital's Q2 2024 Portfolio in Review

As of Q2 2024, Callan Capital held 332 positions worth $1.22B, up 6.8% from $1.14B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Callan Capital deployed $59.9M of net new capital in Q2 2024, opening 35 new positions and adding to 189 existing holdings. Its largest new stake was iShares Core S&P Mid-Cap ETF: 65,165 shares worth $3.81M.

By sector, the portfolio is most concentrated in Miscellaneous at 82% of assets, down from 86% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Vanguard Tax-Exempt Bond Index Fund, an estimated $1.96M trimmed.

  • Callan Capital's largest Q2 2024 buy was iShares Core S&P Mid-Cap ETF: 65,165 shares worth $3.81M.
  • Callan Capital added most to NVIDIA in Q2 2024, an estimated $18.4M increase.
  • Callan Capital's biggest Q2 2024 reduction was Vanguard Tax-Exempt Bond Index Fund, cutting an estimated $1.96M.
  • Callan Capital fully exited Takeda Pharmaceutical in Q2 2024, selling an estimated $354K.
  • Callan Capital's ten largest holdings make up 46% of its $1.22B portfolio in Q2 2024.
  • Callan Capital opened 35 new positions and closed 18 in Q2 2024.
  • Callan Capital's portfolio value rose 6.8% quarter-over-quarter to $1.22B.

Based on Callan Capital's 13F filing for Q2 2024, filed 12 Aug 2024.